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The role of screening questionnaires in the assessment of risk 
and severity of obstructive sleep apnea — polysomnography 
versus polygraphy
Abstract
Obstructive sleep apnea (OSA) is a disease of significant importance, which may lead to numerous severe clinical consequences. 
The gold standard in the diagnosis of this sleep-related breathing disorder (SRBD) is polysomnography (PSG). However, due to the 
need for high expertise of staff who perform this procedure, its complexity, and relatively low availability, some simpler substitutes 
have been developed; among them is polygraphy (PG), which is most widely used.
Also, there is a variety of questionnaires suitable to assess the pre-test probability and severity of OSA. The most frequently used 
ones are the STOP-BANG questionnaire (SBQ), NoSAS questionnaire, and Berlin questionnaire (BQ). However, they have different 
sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) when being used in various populations. 
The aim of this study is to provide a concise and clinically-oriented review of the most frequently used questionnaires, with special 
attention to its strengths and limitations. Moreover, we discuss whether PSG or PG would be more preferred for confirming OSA 
diagnosis with the highest likelihood.
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Introduction
Obstructive sleep apnea (OSA) is a disease of 
significant importance, characterized by repeti-
tive pauses in breathing during sleep, caused by 
upper respiratory tract collapses [1]. Considering 
the prevalence of OSA and its physiologic conse-
quences, in certain patients, the time to establish 
correct diagnosis in polysomnography (PSG) is 
of great clinical importance. According to some 
previous estimates, OSA affects 3 to 7% of adult 
men and 2 to 5% of adult women in the gener-
al population [2]. There is also an association 
between the risk of OSA development and age, 
accounting for even higher disproportions among 
genders (78% in women to 90% in men) [3, 4].
OSA is characterized by the recurrent ces-
sation of breathing (apneas) or partial upper 
airway obstruction (hypopneas) during sleep. 
Apnea-hypopnea index (AHI) is a widely used 
measurement for indicating the severity of OSA 
[1, 5]. Depending on the numbers of apneas and 
hypopneas per hour, OSAS can be classified as 
mild (AHI ≥ 5, to < 15), moderate (AHI ≥ 15 to < 
30) or severe (AHI ≥ 30) [6]. 
Several risk factors for OSA development 
have been identified, including obesity, older age, 
male sex, and neck circumference [7, 8]. Various 
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studies also showed the association of OSA and 
hypertension, highlighting that elevated morn-
ing diastolic blood pressure may be one of the 
symptoms related to OSA [8, 9]. Other symptoms 
reported by patients which indicate OSA include 
snoring, breathing pauses noticed by a bed part-
ner, morning headaches, and daytime sleepiness 
[8]. These measurable and reported features are 
used in some questionnaires for assessing OSA 
probability. 
OSA leads to severe clinical consequenc-
es. Several population-based studies have report-
ed that OSA escalates the risk of hypertension, 
cardiovascular events, metabolic and endocrine 
disorders, underscoring the need for a timely 
diagnosis and treatment [10–13]. Also, a variety 
of studies show a considerable indirect effect of 
OSA on traffic accidents, accidents during work 
and loss of productivity [14–17]. Consequently, 
patients with a high pre-test probability of OSA 
should be prioritized to sleep examinations. 
According to the American Academy of Sleep 
Medicine Clinical Practice Guideline, sleep stud-
ies have been categorized as Type I, Type II, Type 
III and Type IV [18]. Type I is in-laboratory full 
polysomnography (PSG). It includes electroen-
cephalogram (EEG), electrooculogram (EOG), 
chin electromyogram (EOM), electrocardiography 
(ECG), respiratory airflow, respiratory movements, 
leg movements, oxygen saturation and notification 
of body position [19]. Type II studies use the same 
monitoring sensors as Type I, but are unattend-
ed and can be performed outside of the sleep 
laboratory [18]. Type III studies use devices that 
measure limited cardiopulmonary parameters at 
a minimum of four channels (airflow, respiratory 
effort, pulse rate and oxygen saturation) [19]. They 
are divided into cardiorespiratory polygraphy (PG) 
and portable home monitors. Type IV studies are 
limited channel devices, which further include 
oxygen saturation, pulse rate, single respiratory 
effort signal or airflow. All the above-mentioned 
studies are collected in Table 1. 
The gold standard for OSA diagnosis is PSG. 
Moreover, the clinical application of this meth-
od goes beyond OSA. PSG is recommended not 
only for the detection of sleep-related breathing 
disorders (SRBD) like OSA, central sleep apnea 
syndrome, Cheyne-Stokes respiration and al-
veolar hypoventilation syndrome, but also for 
narcolepsy, parasomnias, sleep-related seizure 
disorders, restless legs syndrome and periodic 
limb movement sleep disorder [20]. However, 
PSG is a relatively expensive and not widely 
available procedure, which requires well-trained 
personnel. Furthermore, in the time of decreased 
availability of health service, like during the pan-
demic of SARS-CoV-2, PSG would be even more 
unobtainable. Polygraphy (PG) is one of the ex-
amples of type 3 devices, and has been proposed 
to be a substitute for PSG for assessing patients 
with a high pre-test probability of OSA [21]. These 
devices do not detect arousals during sleep, and 
the AHI obtained from them is usually lower than 
the result achieved from PSG [20]. Therefore, the 
patients still have to undergo PSG and the time 
for proper diagnosis extends. The main advantage 
of using PG, however, is cost-effectiveness and 
feasibility of use [22]. 
Review of the literature of the field shows 
that there is a variety of questionnaires suitable 
for assessing the pre-test probability and severity 
of OSA (Table 2). The questionnaires are easy-to-
use and low-cost tools used by sleep specialists 
all over the world, however, they have different 
sensitivity, specificity, positive predictive value 
(PPV) and negative predictive value (NPV) when 
being used in various populations. 
Table 1. Categories of sleep studies 
Type 1 Type 2 Type 3 Type 4 
Stand in-laboratory techni-
cian-attended PSG 
Full unattended, ambulatory 
overnight PSG 
Cardiorespiratory PG or portable 
home monitors 
Limited channel devices 
Consists of: EEG, EOG, EMG, 
ECG, respiratory airflow, respi-
ratory movements, leg move-
ments, oxygen saturation and 
notification of body position 
Consists of basic channels 
named in type 1 
Minimum four channels: airflow, 
respiratory effort, pulse rate and 
oxygen saturation 
Consists of: oxygen saturation, 
pulse rate, single respiratory 
effort signal and/or airflow 
Optional parameters: more EEG 
channels, leg EMG, body posi-
tion channel, snoring detection 
Optional channels may differ be-
tween available technologies 
Optional channels: body posi-
tion, one electrophysiological 
channel (e.g. ECG or leg EMG), 
actigraphy 
Optional channels: body position, 
snoring sensor and/or pho-
toplethysmographic pulse wave 
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Therefore, the aim of our study is to provide 
a brief and clinically-oriented review of the most 
frequently used questionnaires for OSA examina-
tion, with special attention to its strengths and 
limitations. Moreover, we discuss whether PSG 
or PG should be used to confirm the diagnosis of 
OSA with the highest likelihood.
STOP-Bang questionnaire
The STOP questionnaire was developed 
due to a need for creating a user-friendly, quick 
and concise questionnaire for OSA screening in 
surgical patients at preoperative clinics [23, 24]. 
It includes four „yes/no” questions referring to 
snoring, tiredness, observed apnea and pressure 
(STOP). The STOP-BANG was developed to fur-
ther improve the sensitivity of this questionnaire 
and to detect patients, especially with moderate 
and severe OSA [23]. It consists of subjective 
perception as well as clinical characteristics, with 
a total of 8 items. The acronym BANG stems from 
the first letters of the following features: body 
mass index, age, neck circumference (in male ≥ 
43, in female ≥ 41), gender (BANG), which are 
assessed while completing this questionnaire. 
These features are also described by „yes/no” 
answers which make the scale quick and simple 
to fill out. For each question, answering “yes” 
scores 1 and “no” response scores 0. Score 1 is 
obtained for age > 50 years old, neck circumfer-
ence in male ≥ 43 cm and in female ≥ 41 cm and 
BMI > 35 kg/m2. The total score ranges from 0 to 
8 points (Table 3). 
Numerous studies indicated the widespread 
use of STOP-BANG questionnaire (SBQ) [25–28]. 
For example, SBQ has been used for detecting 
OSA in pregnant women (second trimester), in 
highway bus drivers, in obese and surgical pa-
tients [25–29]. Additionally, SBQ is thought to be 
an excellent tool for screening moderate to severe 
OSA in adults with Down Syndrome [30]. Despite 
validation in multiple various populations, SBQ 
appears to be less useful in patients with chronic 
kidney disease and end-stage renal disease [31]. 
On the contrary, a study conducted on patients 
with atrial fibrillation reported high sensitivity 
(89%) at the cost of low specificity (36%) [32]. 
The PPV was 89%, and the NPV was 36%.
SBQ is also commonly used in the sleep clin-
ic, where the prevalence of OSA is high. In the 
study conducted by Reis et al., score ≥ 3 had a sen-
sitivity and PPV for all OSA of 93.4% and 86.6%, 
respectively [33]. The increase in the SBQ score 
accompanies the rise in the probability of OSA, to 
95% with a score of 6. Moreover, with higher SBQ 
score, the greater the probability of severe sleep 
apnea would be. Reis et al. also showed that an 
SBQ score of 3 and 2 had an NPV for moderate or 
severe OSA of 85.3% and 91.7%, respectively. It 
means that a score lower than 3 showed high dis-
criminative power to exclude moderate to severe 
OSA. Similar results were obtained by Farney et 
al. because their research probability of having 
OSA in patients with a score of ≥ 3 was 85.1% 
[34]. Also, as in a previous study, with any score 
of > 3, the probability of detecting severe OSA 
continuously increases. Recently, we assessed 
Table 2. Questionnaires used to assess pre-test probability and severity of OSA
Questionnaire 
name
Scoring Cut-off value Advantages Disadvantages 
STOP-Bang From 0 to 8 points 3 points Helpful as a screening tool for 
detection of OSA in sleep clinic 
and surgical population.
The greater the score, the greater 
probability of severe OSA 
Composed of subjective 
and objective responses.
NoSAS From 0 to 17 points 7 points Easy to use because of consisting 
only 5 items.
Nearly all of the items can be easily 
measured and are objective.





High risk: if there are 2 or more cate-
gories where the score is positive.
Low risk: if there is only 1 or no cat-
egories where the score is positive.
— Nearly all of questions 
can be subjectively un-
derstood.
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the SBQ’s accuracy in positional OSA in adults 
[35]. As in previous studies, we used a cut-off 
score of 3, and we found high sensitivity (96.9%), 
but the specificity was only 16.7% in our study 
population. For the probability of OSAS diagnosis 
with SBQ ≥ 3, the PPV was 79.2% and NPV was 
62.0%. In the study conducted by Boyton et al. 
using a cut-off of ≥ 3 points, for AHI levels of > 5, 
> 15, and > 30, respective sensitivities were 82.2, 
93.2 and 96.8% and specificities were 48.0%, 
40.5%, and 33.1% [36]. PPV and NPV for AHI 
> 5 were 79.2% and 28.3%, for AHI > 15 were 
52.2% and 66.7%, for AHI > 30 were 36.4% and 
96.3%, respectively.
When it comes to the general population, 
Tan et al. showed the sensitivity of a STOP-Bang 
score of ≥ 3 was 66.2% for detecting AHI ≥ 15, 
and 69.2% for detecting AHI ≥ 30. The specific-
ities were 74.7% and 67.1%, respectively. The 
NPVs were 85% for moderate-to-severe OSA and 
94.8% for severe OSA. The PPVs were 50.6% and 
20.2%, respectively [37]. Investigations carried 
by Silva et al. [38] revealed that the sensitivity of 
SBQ score ≥ 3 was 87% to detect moderate-to-se-
vere OSA and 70.4% to detect severe OSA. The 
specificities were 43.3% and 59.5%, respectively. 
However, there is an insufficient amount of data 
in the general population and further investiga-
tion is needed. 
In a meta-analysis of seventeen studies in-
cluding a total of 9,206 patients, the accuracy 
of the STOP-Bang questionnaire was validated 
by PSG [39]. In the sleep clinic population, the 
pooled sensitivity of a STOP-Bang score ≥ 3 to pre-
dict any OSA, moderate-to-severe and severe OSA 
was 90%, 94% and 96%, respectively, whereas the 
pooled specificity was relatively low (49%, 34% 
and 25%, respectively). The PPVs for any OSA, 
moderate-to-severe, and severe OSA were as fol-
lows: 91%, 72% and 48%, whereas the NPVs were 
46%, 75% and 90%, respectively. This review also 
showed relatively high sensitivity of SBQ in de-
tecting OSA in the surgical population (91%). The 
specificity at the same cut-off is modest, ranging 
from 32% in the surgical population to 34% in 
the sleep clinic. In another meta-analysis, the 
researchers also observed that the STOP-BANG 
has great sensitivity for detecting OSA, but its 
limitation is specificity [40]. They showed that 
SBQ is superior for detecting mild, moderate, 
and severe OSA than other questionnaires, but 
has the significant impact on the population on 
which it is used. Summarizing, the discussed 
questionnaire is the best screening tool for the 
detection of OSA in the sleep clinic and surgical 
population.
NoSAS
The NoSAS was developed as a new screening 
tool for recognizing patients at risk of sleep-disor-
dered breathing [41]. The NoSAS score consists 
of five items and a certain amount of points is 
given for each item (Table 4). Neck circumference 
> 40 cm is rated at 4 points, body mass index 
(BMI) between 25 and < 30 kg/m2 — 3 points, 
BMI ≥30 kg/m2 — 5 points, 4 points for being 
older than 55 years, and 2 points for being male. 
Consequently, the total score ranges from 0 to 
17 points. 
In the HypnoLaus study conducted on 
2,168 participants, a score of 8 was used as 
a threshold [41]. The score had an AUC of 0.74, 
a PPV — 0.47 and an NPV — 0.90. Similar re-
sults were obtained from the EPISONO cohort 
— the NoSAS score had an AUC of 0.81, a PPV 
of 0.33 and an NPV of 0.98. Additionally, in this 
research, the NoSAS was compared with the 
STOP-BANG questionnaire and Berlin question-
naire, and found to have a significantly better 
outcome. The same threshold was used in a dif-
ferent study by Peng et al., and the results were as 
Table 3. STOP-Bang questionnaire 
STOP Do you SNORE loudly (louder than talking or loud enough to be heard through closed doors)? Yes No
Do you often feel TIRED, fatigued, or sleepy during daytime? Yes No
Has anyone OBSERVED you stop breathing during your sleep? Yes No
Do you have or are you being treated for high blood PRESSURE? Yes No
BANG BMI more than 35kg/m2? Yes No
AGE over 50 years old? Yes No
NECK circumference >16 inches (40cm)? Yes No
GENDER: Male? Yes No
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follows: to predict AHI ≥ 5, AHI ≥ 15 and AHI > 
30, the sensitivity and specificity were 0.590 and 
0.707, 0.649 and 0.626, and 0.644 and 0.562, 
respectively [42]. When the AHI ≥ 5 was used 
for diagnosing sleep-disordered breathing, the 
NoSAS score had the largest area under the curve 
compared to other questionnaires in the study 
(the Berlin questionnaire was the second one). 
Another study in patients referred by primary care 
physicians to the sleep unit by Coutinho Costa 
[43] demonstrated the sensitivity and PPV were 
94.3% and 87.6% for all OSA severity categories, 
using a cut-off value of 7 points. With the same 
cut-off, the NPV for all OSA was 50%. In another 
study conducted on a group of patients suspected 
of sleep-disordered breathing, the NoSAS showed 
71.6% sensitivity, 68.7% specificity, PPV 89.0% 
and NPV 40.7% for detecting OSA [44].
The main advantage of the NoSAS question-
naire is its small number of items which can be 
easily and objectively measured. Additionally, 
due to its ease of use, it can be applied in de-
manding populations, for example in patients 
with major depression [45].
In a study conducted by Tan et al. [46] in 
a multi-ethnic Asian cohort, the sensitivity, speci-
ficity, NPV and PPV of the NoSAS score to predict 
severe SRBM were 69.2%, 73.1%, 95.2%, and 
23.7%, respectively. Therefore, the researchers 
proved that NoSAS performed similarly to the 
STOP-Bang and Berlin questionnaires. One of the 
major limitations of this study, however, is that 
they used type 3 portable monitors.
Berlin questionnaire
The Berlin questionnaire (BQ) was initially 
developed in 1999 to identify patients at risk for 
OSA in primary care [47]. The Berlin question-
naire is divided into three categories (Table 5). 
The first of them is related to snoring, the second 
part is about sleepiness and fatigue, and the last 
one is about the presence of hypertension. In 
category 1, high risk was defined as persistent 
symptoms in two or more questions about their 
snoring. In category 2, high risk was defined as 
persistent waketime sleepiness, drowsy driving, 
or both. In category 3, high risk was defined as 
a history of high blood pressure. Patients at high 
risk in at least two categories are considered to 
be also at elevated risk for OSA. 
There are numerous studies that evaluated 
the Berlin questionnaire validity for OSA risk 
in sleep clinic populations [48–52]. Saleh et al. 
showed that the sensitivity, specificity, PPV and 
NPV were as follows: 97%, 90%, 96% and 93% 
against AHI > 5 [48]. A similar sensitivity for 
predicting OSA was found by El-Sayed (95%), 
but they noted a sensitivity of only 23%. The 
PPV and NPV in the latter study were 92% and 
33%, respectively [51]. The researcher also as-
sessed these parameters at AHI > 15 and AHI 
> 30 cut-offs. The BQ had high sensitivity for 
detecting moderate-to-severe (95%) and severe 
OSA (97%), but very low specificity for detecting 
moderate-to-severe (7%) and severe OSA (10%). 
In a study by Amra et al., the sensitivity, speci-
ficity, PPV and NPV of the BQ for OSA diagnosis 
with AHI > 5 were found to be 84%, 62%, 96%, 
25%, respectively [50]. In contrast, the values at 
AHI ≥ 15 were 87.9%, 36.7%, 75.3%, 58.0% and 
at AHI ≥ 30 were 87.8%, 26.5%, 51.5%, 70.9%. 
The study conducted by Ng et al. showed that the 
BQ was unreliable in patients in predicting OSAS 
by PSG-AHI [53]. A different study demonstrated 
that the BQ has a high sensitivity (87.2%), but 
low specificity (11.8%) with PPV 73.2% and an 
NPV 25.0% [54].
There was also a study carried out on the 
general population [55], which concluded that 
the high-risk group based on the BQ predicted an 
AHI ≥ 5 with a sensitivity of 69% and specificity 
of 83%. On the other hand, a study in a generally 
healthy elderly population revealed that the BQ 
is not a satisfactory tool to predict OSA [56]. The 
BQ is also considered to be a poor predictor of 
OSA in a random group of patients undergoing 
pulmonary rehabilitation [57]. 
It is also worth highlighting that OSA was 
also found to be associated with idiopathic intra-
cranial hypertension (IIH) [58]. The sensitivity of 
the BQ in IIH patients was 83.3%, the specificity 
was 58.3%, the PPV was 75%, and the NPV was 
70%, respectively [59].
In the meta-analysis conducted by Senaratna 
et al. [60], the Berlin questionnaire was proven to 
have good sensitivity for detecting clinically rel-
Table 4. NoSAS questionnaire
Feature Points
Neck circumference 4
BMI 25 to < 30 kg/m2 3
BMI ≥ 30 kg/m2 5
Snoring 2
Age > 55 years 4
Sex (male) 2
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evant OSA (≥ 15 AHI) in the sleep clinic popula-
tion. In the other populations, it had modest-high 
sensitivity for detecting clinically relevant OSA. 
Additionally, its specificity was low in all pop-
ulations. In another meta-analysis, the BQ with 
the Sleep Disorders Questionnaire were the two 
most accurate questionnaires in preoperative use, 
but the researchers also observed that no single 
prediction tool functions as an ideal preoperative 
test [61].
Sleep Apnea Clinical Score 
The Sleep Apnea Clinical Score (SACS) is 
a relatively new screening tool which aims to 
predict the presence of OSA, based on snoring, 
witnessed episodes of apnea, neck circumference 
and systemic hypertension [62]. Depending on the 
OSA severities indicated by AHI levels, the SACS 
had the sensitivity ranging from 39% to 51% and 
specificity ranging from 90% to 88% in primary 
care population [63]. In the study conducted on 
91 patients with COPD, the SACS performed bet-
ter than the BQ and ESS in predicting OSA [62]. 
However, the data regarding this questionnaire 
are limited and it is required to conduct more 
studies assessing a predicting role and utility 
compared with other scales.
Epworth Sleepiness Scale 
The Epworth Sleepiness Scale (ESS) consist 
of 8 items in which patients rate their tendency 
to falling asleep in certain situations during 
daytime. Each item is rated from 0 to 3, where ‘0’ 
indicates no probability of falling asleep and ‘3’ 
indicates high probability [64]. The score greater 
than 10 is a predictor of the presence of excessive 
daytime  sleepiness. The studies showed that 
this questionnaire is not a useful tool neither for 
OSA diagnosis nor to assess its severity [65, 66]. 
On the other hand, Hardinge et al. measured the 
intensity of daytime sleepiness before and after 
continuous positive airway pressure (CPAP) and 
came to conclusion that it is a great tool for mon-
itoring the effectiveness of OSA treatment [67]. 
Table 5. Berlin questionnaire 
Category 1
Do you snore? Yes No Don’t know
Your snoring is... Slightly louder than 
breathing
As loud as talking Louder than talking Very loud, can be 
heard in adjacent 
rooms
How often do you snore? Nearly every day 3–4 times a week 1–2 times a week 1–2 times a month Never or nearly 
never
Has your snoring ever 
bothered other people?
Yes No
Has anyone noticed that 
you quit breathing during 
your sleep?
Nearly every day 3–4 times a week 1–2 times a week 1–2 times a month Never or nearly 
never
Category 2
How often do you feel 
tired or fatigued after your 
sleep?
Nearly every day 3–4 times a week 1–2 times a week 1–2 times a month Never or nearly 
never
During your wake time, 
do you feel tired, fatigued, 
or not up to par?
Nearly every day 3–4 times a week 1–2 times a week 1–2 times a month Never or nearly 
never
Have you ever nodded 
off or fallen asleep while 
driving a vehicle?
Yes No
If yes, how often does it 
occur?
Nearly every day 3–4 times a week 1–2 times a week 1–2 times a month Never or nearly 
never
Category 3
Do you have high blood 
pressure?
Yes No Don’t know
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Discussion 
It is worth pointing out that all of the present-
ed questionnaires differ from each other in terms 
of objectivity of the answers. The STOP-BANG 
has 3 of 8 points which are subjective respons-
es, the NoSAS has only 2 of 17 points which are 
subjective responses, whereas BQ is practically 
composed of questions which can be subjectively 
understood (despite the occurrence of hyperten-
sion). That creates a problem in understanding or 
subjective perception of a certain ailment.
The screening questionnaire for OSA should 
be accessible to perform, precise and appropriate 
for different populations. In our review, most of 
the presented studies focused on the validation of 
questionnaires in the sleep clinic patients, where 
the prevalence of OSA is high. Sleep clinics may 
demand questionnaires of high sensitivity, like 
SBQ, in order to accurately diagnose patients 
with OSA. Additionally, when the result of SBQ 
is 5 or higher, it may prompt clinicians to carry 
out PSG sooner, because the higher the score, 
the greater probability of severe OSA would be. 
In some populations, for example in the surgical 
population, time of predicting OSA is crucial. 
SBQ is a quick and verified tool for predicting 
this SRBM and thus will be clinically convenient 
and applicable under time-sensitive situation. 
On the other hand, in the general population, 
the high specificity of questionnaire may prevent 
unnecessary referral for PSG. 
One of the mentioned studies [41], which 
was carried out on a sizable population, indicat-
ed that the NoSAS, as a new screening tool, had 
greater diagnostic accuracy than the SBQ or BQ. 
It consists of only 5 items, practically all of them 
are objective and it seems to be a very quick, easy 
and precise tool for prediction of OSA. In a dif-
ferent study, conduced on adult patients referred 
to the sleep center, the NoSAS showed a better 
discrimination capacity compared to the Berlin 
and STOP-Bang [68]. 
None of the presented questionnaires was 
sensitive and specific enough to desist further 
investigations. If PSG is available, it should be 
used as a gold standard in the diagnostic path. 
In case of the absence of this expensive and 
time-consuming examination, PG should be ap-
plied as a faster and easier option. 
In one of the studies [69], the researchers 
provided a valuable finding that a symptomat-
ic patient with BMI lower than 25.0 kg/m2 has 
a very low chance (< 3%) of AHI ≥ 15 events/h 
in the lateral sleep position. Therefore, positional 
treatment can be an alternative applied prior to 
conducting PSG in that group of patients. 
The ESS is a well described tool for assessing 
daytime sleepiness, but it is not recommended as 
a questionnaire for OSA diagnosis. 
Summary 
The SBQ seems to be a useful screening 
tool in the sleep clinic and surgical population. 
However, the current literature review shows 
that studies suggesting which questionnaire can 
be useful in the general population are sparse. 
Therefore, further research in this field would 
be of great clinical importance. The presented 
questionnaires may have some utility in assess-
ing the likelihood of OSA in patient, albeit they 
do not give satisfactory level of certainty in the 
detection or exclusion of this SRBD. PSG remains 
a gold standard for OSA detection, and PG should 
constitute the first alternative only in case of its 
unavailability.
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